HRT and Breast Cancer: What Women Deserve to Know
One of the most common questions women ask me when we’re discussing hormone replacement therapy (HRT) is:
“But doesn’t estrogen cause breast cancer?”
For many women, that concern is enough to stop the conversation before it really begins.
The relationship between hormone therapy and breast cancer is more nuanced than the headlines many women have heard for the past two decades. The type of hormone therapy, how long it is used, and your individual health history all matter.
And perhaps most importantly, risk needs context.
Does HRT Cause Breast Cancer?
There isn’t a simple yes-or-no answer.
Much of today’s fear about HRT can be traced back to the initial Women’s Health Initiative (WHI) results released in 2002. The public message that followed was often much simpler than the actual findings: Hormones are dangerous.
But the WHI did not show the same breast cancer findings for all hormone therapy.
Women with a uterus who received conjugated equine estrogen plus medroxyprogesterone acetate had a higher incidence of breast cancer than women receiving placebo. Women who had undergone hysterectomy and received estrogen alone, however, had a lower incidence of breast cancer during long-term follow-up.
That’s why the statement “estrogen causes breast cancer” doesn’t accurately describe what the WHI found.
Current guidance from The Menopause Society also emphasizes that the benefits and risks of HRT vary based on factors such as the type of hormones used, duration of treatment, a woman’s age, when treatment is started, and her individual health history.
How Big Is the Breast Cancer Risk With Combined HRT?
This is where I think women deserve more context.
Hearing that something “increases your risk” can sound frightening without knowing how much the risk actually increases.
Combined estrogen-progestogen therapy has been associated with a small increase in breast cancer risk, particularly with longer use. But other common factors—including alcohol use and excess body weight after menopause—are also established breast cancer risk factors and may carry risks of a similar or greater magnitude depending on the level of exposure.
Yet we rarely hear women talk about a glass of wine with the same fear that has surrounded HRT for the past two decades.
That doesn’t mean we should dismiss the potential breast cancer risk associated with hormone therapy. It means we should put it in perspective and discuss it alongside other factors that influence breast cancer risk.
The question shouldn’t simply be:
“Does HRT have any risk?”
Almost every medical treatment has potential benefits and risks.
A better question is:
“What are my individual risks, what are the potential benefits, and how do those compare for me?”
Why Does Estrogen Alone Differ From Combined HRT?
Women who have had a hysterectomy generally do not need progesterone or another progestogen for uterine protection and may be able to use estrogen alone.
In approximately 20 years of follow-up from the WHI randomized trial, women assigned to conjugated equine estrogen alone had a lower incidence of breast cancer and lower breast cancer mortality than women assigned to placebo.
That doesn’t mean estrogen prevents breast cancer or that every form of estrogen has been proven to produce the same result. But it does show why saying simply that “estrogen causes breast cancer” is misleading.
If you still have your uterus, the situation is different. Systemic estrogen stimulates the uterine lining, and using it without adequate protection increases the risk of endometrial hyperplasia and endometrial cancer.
That’s why women with a uterus who use systemic estrogen generally also need progesterone or another progestogen to protect the uterine lining.
Does the Type of Progesterone Matter?
Possibly—and this is another reason we shouldn’t talk about all HRT as though it were one medication.
The combined-treatment arm of the WHI specifically studied conjugated equine estrogen with medroxyprogesterone acetate (MPA). It did not study every estrogen and progesterone formulation prescribed today.
Observational research suggests breast cancer risk may differ among different progestogens, but we don’t have the same level of long-term randomized evidence for every modern regimen.
So while the WHI gives us important information, its findings shouldn’t automatically be used to assign the exact same level of risk to every hormone formulation.
Can I Take HRT If Breast Cancer Runs in My Family?
Having a family history of breast cancer does not automatically mean you cannot use hormone therapy.
Your personal and family history, age, breast screening history, and overall risk factors should be considered together. For women with a strong family history, a more formal breast cancer risk assessment or genetic counseling may also be appropriate.
A personal history of breast cancer is different from a family history. Systemic hormone therapy is generally not recommended after breast cancer, although individual circumstances may require discussion with a woman’s oncology and menopause-care teams.
And whether you use HRT or not, continue recommended breast cancer screening and talk with your physician about any new breast changes.
How Should I Decide Whether HRT Is Right for Me?
I don’t think that question can be answered without knowing the woman sitting in front of me.
Hormone therapy is the most effective treatment for menopausal hot flashes and night sweats. It can also improve genitourinary symptoms and help prevent bone loss and fractures.
For many healthy women younger than 60 or within 10 years of menopause onset who do not have contraindications, the overall benefit-risk balance of hormone therapy is favorable when used for appropriate indications.
So I don’t want women making the decision based solely on the question:
“Could HRT increase my breast cancer risk?
I want us to talk about your symptoms, your health history, your breast cancer risk, your bone health, your cardiovascular health, the type of hormone therapy being considered, and what matters to you.
That’s what individualized care should look like.
The Bottom Line
Breast Cancer Awareness Month is an important reminder to schedule your mammogram and understand your breast cancer risk.
It’s also an opportunity to make sure fear of breast cancer isn’t preventing you from getting accurate information about your health.
HRT and breast cancer cannot be reduced to “estrogen causes cancer.” Estrogen-alone and combined hormone therapy have different findings, formulation and duration matter, and breast cancer risk should be considered alongside other established risk factors such as alcohol use and excess body weight after menopause.
You deserve to make decisions based on accurate information and your individual health—not fear or a headline from more than 20 years ago.
Frequently Asked Questions
Does estrogen cause breast cancer?
The evidence doesn’t support such a simple statement. In the WHI randomized trials, the breast cancer findings differed between women receiving combined estrogen-progestogen therapy and women receiving estrogen alone.
Is breast cancer risk higher with HRT than with alcohol?
It depends on the hormone regimen, duration of use, and amount of alcohol consumed. Alcohol is an established breast cancer risk factor, and at some levels of consumption its associated risk can be comparable to or greater than estimates associated with combined HRT.
Is obesity a breast cancer risk after menopause?
Yes. Excess body weight after menopause is an established breast cancer risk factor and is important to consider when looking at a woman’s overall risk.
Can I use HRT if my mother had breast cancer?
A family history of breast cancer does not automatically exclude you from hormone therapy. Your individual risk should be evaluated, and some women may benefit from formal breast cancer risk assessment or genetic counseling.
Can I take estrogen without progesterone?
Women who have had a hysterectomy may be able to use estrogen alone. If you have a uterus and use systemic estrogen, progesterone or another progestogen is generally needed to protect the uterine lining.
Does the type of progesterone matter?
It may. The WHI combined-therapy trial specifically studied medroxyprogesterone acetate with conjugated equine estrogen, and observational evidence suggests breast cancer risk may differ among progestogens. We don’t have equivalent long-term randomized evidence for every modern regimen.
Have Questions About HRT and Breast Cancer Risk?
Understanding your individual breast cancer risk can help you make informed decisions about hormone therapy and your overall health.